@madamswer
Re "Yet, instead, it has bought another party who is a mere MSB licensee.... strange corporate machinations, I find."
It can only mean that the count of "bone-headed number crunchers" masquerading as large, revenue generating organisations is growing.
- Forums
- ASX - By Stock
- MSB
- Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish
MSB
mesoblast limited
Add to My Watchlist
3.88%
!
$2.23
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-61
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
